Literature DB >> 26666237

Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients.

Betül Vatankulu1, Sabire Yilmaz Aksoy2, Sait Sager3, Metin Halaç3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26666237     DOI： 10.1007/s00259-015-3284-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

1.  18F-FDG PET-CT in the evaluation of paraneoplastic syndromes: experience at a regional oncology centre.

Authors:  Sriram Vaidyanathan; Catherine Pennington; Chen Yi Ng; Fat Wui Poon; Sai Han
Journal:  Nucl Med Commun       Date:  2012-08       Impact factor: 1.690

2.  PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit.

Authors:  M Hadjivassiliou; S J Alder; E J R Van Beek; M B Hanney; E Lorenz; D G Rao; B Sharrack; W B Tindale
Journal:  Acta Neurol Scand       Date:  2008-10-06       Impact factor: 3.209

3.  Utility of F-18 FDG PET/CT in screening for paraneoplastic neurological syndromes.

Authors:  Akiyuki Matsuhisa; Akira Toriihara; Kazunori Kubota; Tomoko Makino; Hidehiro Mizusawa; Hitoshi Shibuya
Journal:  Clin Nucl Med       Date:  2012-01       Impact factor: 7.794

4.  Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome.

Authors:  M Solimena; F Folli; R Aparisi; G Pozza; P De Camilli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

5.  Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients.

Authors:  Stine Bjørn Kristensen; Søren Hess; Henrik Petersen; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-21       Impact factor: 9.236

6.  Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.

Authors:  B Vatankulu; S Yilmaz Aksoy; S Asa; S Sager; H B Sayman; M Halac; K Sonmezoglu
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2015-08-08       Impact factor: 1.359
  6 in total
  1 in total

1.  Reply to: "Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients": By Betül Vatankulu, Sabire Yilmaz Aksoy, Sait Sager, Metin Halaç.

Authors:  Stine Bjørn Kristensen; Søren Hess; Henrik Petersen; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.